This study provides the results of our attempt to identify new BRCA1/2 mutations in HBOC patients and estimate their usefulness for molecular screening to spot hidden hereditary breast/ovarian cancer patients without a significant family history. Here, BRCA1 is linked to ovarian carcinoma.